News Biotech IPO market heats up as BioHaven's debut impresses BioHaven raises $168 million with biggest biotech IPO seen this year.
Views & Analysis Ultra-rare disease drugs: has access in England just got har... Gaining access to ultra-orphan drugs could become much more difficult.
Views & Analysis Getting a rarer perspective Benefitting from insights from focus groups with rare disease patients.
News Biogen shares up after strong launch for rare disease drug US insurers are covering the treatment, despite high price.
News EU regulators back two more orphan drugs, question of pricin... Two orphan medicines are heading towards the European market, after regulators recommended rare disease drugs from Biogen and BioMarin.
News Are biotech IPOs back in fashion? After a slow first quarter, biotech IPOs may finally start to come into vogue in the coming months as a series of companies announced plans to go public.
News GBL joins CVC in €10.7bn takeover bid for Recordati A consortium of investors has made a €10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
